Literature DB >> 8252912

The effects of variation of cryopreservation protocols on the immunogenicity of allogeneic skin grafts.

E Ingham1, J B Matthews, J N Kearney, G Gowland.   

Abstract

The use of allografts to effect wound closure on full thickness skin injuries is limited by unpredictable graft rejection times. If the period of graft take could be extended, the use of allografts would reduce the morbidity and mortality associated with these wounds. This study evaluated the effects of variation in the cryopreservation protocol on the viability and immunogenicity of skin using a murine model system. Immunogenicity was assessed by the stimulatory activity of C3H (H-2K) skin-derived epidermal cells (EC) in primary one-way EC/lymphocyte reactions with BALB/c (H-2d) and CBA (H-2K) responder lymphocytes. Viability was determined by measuring tetrazolium reductase activity. The following cryopreservation protocols were assessed: freezing at 1, 30, 64, and > 100 degrees C/min in 10 and 15% (v/v) Me2SO and freezing at 30 degrees C/min in 5 to 20% (v/v) Me2SO or glycerol. A cryopreservation protocol of 30 degrees C/min in 15% (v/v) Me2SO proved optimal for murine skin allograft storage and immunomodulation. The viability of skin treated by this protocol was maintained (78% of fresh skin viability, no significant difference analysis of variance). The stimulatory capacity of treated EC for H-2K and H-2d lymphocytes was 5 +/- 4 and 5 +/- 9% (+/- 95% confidence limits) of fresh EC (100%) activity. Langerhans cell numbers in epidermal sheets and EC suspensions did not correlate with the stimulatory capacity of fresh and treated EC for allogeneic lymphocytes. A functional impairment of Langerhans cell immunostimulatory capacity was implied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252912     DOI: 10.1006/cryo.1993.1045

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  5 in total

1.  The cryopreservation of composite tissues: Principles and recent advancement on cryopreservation of different type of tissues.

Authors:  Joseph Bakhach
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

2.  Allowable warm ischemic time to tracheal extraction for allotransplantation of cryopreserved trachea.

Authors:  Yasuhiro Kitamura; Nobuyoshi Shimizu; Motoi Aoe; Hiroshi Date; Itaru Nagahiro; Akio Andou
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-04

3.  Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.

Authors:  Gilbert Verbeken; Gunther Verween; Daniel De Vos; Bruno Pascual; Peter De Corte; Cornelia Richters; Arlette De Coninck; Diane Roseeuw; Nadine Ectors; Thomas Rose; Serge Jennes; Jean-Paul Pirnay
Journal:  Cell Tissue Bank       Date:  2011-03-01       Impact factor: 1.522

4.  Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures.

Authors:  Jean-Paul Pirnay; Gunther Verween; Bruno Pascual; Gilbert Verbeken; Peter De Corte; Thomas Rose; Serge Jennes; Alain Vanderkelen; Miriam Marichal; Walter Heuninckx; Daniel De Vos
Journal:  Cell Tissue Bank       Date:  2011-04-21       Impact factor: 1.522

5.  Microsurgical tunica albuginea transplantation in an animal model.

Authors:  Salvatore Sansalone; Carla Loreto; Rosario Leonardi; Giuseppe Vespasiani; Giuseppe Musumeci; Claudia Lombardo; Sergio Castorina; Venera Cardile; Rosario Caltabiano
Journal:  Asian J Androl       Date:  2017 Nov-Dec       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.